Literature DB >> 8322246

New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease.

T D Tetley1.   

Abstract

The hypothesis, some 30 years ago, that NE was the sole proteolytic agent responsible for the development of emphysema seems naive in retrospect. The availability of technology to measure NE facilitated the early research into the relationship between NE and lung disease. Despite an abundance of information on the activity of NE in the lung, it will probably require prospective studies in man with specific NE inhibitors or control at the gene level to establish a causal relationship between NE and lung disease. Parallel research has resulted in the isolation and characterisation of NE inhibitors other than PI and, indeed, alternative proteolytic enzymes that might contribute to lung disease. It is perhaps impossible now to think that a single proteinase, however omnipotent it may be, causes lung diseases as diverse as emphysema and fibrosis. An important aspect that is emerging is the interrelationship between proteolytic enzymes produced by different, or sometimes the same, cells that could potentiate tissue proteolysis. The evidence suggests that there is likely to be coordinated action between neutrophils, macrophages, and possibly mesenchymal proteinases which can activate or inactivate each other. In addition, one class of proteinases often appears able to proteolytically inactivate inhibitors of the opposite class, which presumably could amplify proteolysis if it occurred in vivo. Although the work on this aspect of proteinase activity is in its infancy, one suspects that part of the normal regulation of proteinase activity might include compartmentalisation. For example, the neutrophil stores proteinases before appropriate release and can inactivate PI to enable proteolytic action pericellularly, whereas degradation of extracellular matrix by macrophages requires interaction between the cell and matrix which is facilitated by cell receptor bound uPA. Disintegration of these "compartments" due to oedema, proteolysis, or for mechanical reasons could, firstly, expose further extracellular matrix substrates to inflammatory and damaged cell proteinases but, secondly, might enhance proteinase potential by the cooperative action of these enzymes. It seems increasingly likely that, where proteinases play a part, there is a cocktail of proteinases that is characteristic of the injury that develops (fig). What remains unclear is why only a proportion of those susceptible, such as smokers or those with acute lung injury, develop irreversible lung disease. This suggests that there are other factors acquired or inherited that need to be considered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8322246      PMCID: PMC464518          DOI: 10.1136/thx.48.5.560

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  58 in total

1.  Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells.

Authors:  C P Sommerhoff; J A Nadel; C B Basbaum; G H Caughey
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 2.  Tissue destruction by neutrophils.

Authors:  S J Weiss
Journal:  N Engl J Med       Date:  1989-02-09       Impact factor: 91.245

3.  Elastin degradation by human alveolar macrophages. A prominent role of metalloproteinase activity.

Authors:  R M Senior; N L Connolly; J D Cury; H G Welgus; E J Campbell
Journal:  Am Rev Respir Dis       Date:  1989-05

4.  A peptide from alveolar macrophages that releases neutrophil enzymes into the lungs in patients with the adult respiratory distress syndrome.

Authors:  A B Cohen; C MacArthur; S Idell; R Maunder; T Martin; C A Dinarello; D Griffith; J McLarty
Journal:  Am Rev Respir Dis       Date:  1988-05

5.  Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis.

Authors:  C O'Connor; C Odlum; A Van Breda; C Power; M X Fitzgerald
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

6.  The acute effect of cigarette smoking on the neutrophil elastase inhibitory capacity of peripheral lung lavage from asymptomatic volunteers.

Authors:  T D Tetley; S F Smith; A J Winning; J M Foxall; N T Cooke; G H Burton; E Harris; A Guz
Journal:  Eur Respir J       Date:  1989-10       Impact factor: 16.671

7.  Evaluation of elastase and antielastase balance in patients with chronic bronchitis and pulmonary emphysema.

Authors:  J Fujita; N L Nelson; D M Daughton; C A Dobry; J R Spurzem; S Irino; S I Rennard
Journal:  Am Rev Respir Dis       Date:  1990-07

8.  Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases.

Authors:  Y Okada; S Watanabe; I Nakanishi; J Kishi; T Hayakawa; W Watorek; J Travis; H Nagase
Journal:  FEBS Lett       Date:  1988-02-29       Impact factor: 4.124

9.  Cathepsin D from human leukocytes. Purification by affinity chromatography and properties of the enzyme.

Authors:  U C von Clausbruch; H Tschesche
Journal:  Biol Chem Hoppe Seyler       Date:  1988-08

10.  The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.

Authors:  A Estreicher; J Mühlhauser; J L Carpentier; L Orci; J D Vassalli
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

View more
  26 in total

Review 1.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Correlation of matrix metalloproteinase-2 and -9 expression with recurrences in primary spontaneous pneumothorax patients.

Authors:  Wen-Chin Chiu; Yi-Chen Lee; Yu-Han Su; Chee-Yin Chai; Stephen Chu-Sung Hu; Shyng-Shiou F Yuan; Shah-Hwa Chou
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

3.  Augmentation by eosinophils of gelatinase activity in the airway mucosa: comparative effects as a putative mediator of epithelial injury.

Authors:  C A Herbert; M J Arthur; C Robinson
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

4.  Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients.

Authors:  G A Finlay; K J Russell; K J McMahon; E M D'arcy; J B Masterson; M X FitzGerald; C M O'Connor
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

Review 5.  Inflammatory cells in the airways in COPD.

Authors:  R O'Donnell; D Breen; S Wilson; R Djukanovic
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

6.  Cystatin C deficiency in human atherosclerosis and aortic aneurysms.

Authors:  G P Shi; G K Sukhova; A Grubb; A Ducharme; L H Rhode; R T Lee; P M Ridker; P Libby; H A Chapman
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

7.  Modulation of γδ T-cell activation by neutrophil elastase.

Authors:  Nadia Yasmín Towstyka; Carolina Maiumi Shiromizu; Irene Keitelman; Florencia Sabbione; Gabriela Verónica Salamone; Jorge Raúl Geffner; Analía Silvina Trevani; Carolina Cristina Jancic
Journal:  Immunology       Date:  2017-10-05       Impact factor: 7.397

Review 8.  New strategies for treatment of pulmonary fibrosis.

Authors:  S H Phan
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

Review 9.  Matrix metalloproteases and lung disease.

Authors:  C M O'Connor; M X FitzGerald
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

10.  Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis.

Authors:  R Sepper; Y T Konttinen; T Ingman; T Sorsa
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.